ShapeAce announced that the company recently received the “Drug Registration Certificate” for compound topicamide eye drops issued by the State Drug Administration, certificate number 2026S04003, drug approval number H20266471. The registration classification is 4 types of chemicals. The specification is 10ml: topicamide 50 mg and phenylephrine hydrochloride 50 mg. The listing license holder is the company. This drug is suitable for dilating pupils and regulating paralysis for the purpose of diagnosis and treatment. As of the date of disclosure of the announcement, the company's total R&D investment for this drug was approximately RMB 5.146,400. Obtaining a registration certificate this time will further enrich the company's product categories and help optimize product layout.

ShapeAce announced that the company recently received the “Drug Registration Certificate” for compound topicamide eye drops issued by the State Drug Administration, certificate number 2026S04003, drug approval number H20266471. The registration classification is 4 types of chemicals. The specification is 10ml: topicamide 50 mg and phenylephrine hydrochloride 50 mg. The listing license holder is the company. This drug is suitable for dilating pupils and regulating paralysis for the purpose of diagnosis and treatment. As of the date of disclosure of the announcement, the company's total R&D investment for this drug was approximately RMB 5.146,400. Obtaining a registration certificate this time will further enrich the company's product categories and help optimize product layout.